APEX1 and neoplasm: Thus, increased APE1 acetylation levels in tumor cells and the resulting inhibition of N-terminal limited proteolysis of APE1 represent a novel mechanism by which cancer cells maintain APE1 functions and thereby sustain expression of genes associated with cell cycle progression and survival.